Ekso Bionics Stock Price, News & Analysis (NASDAQ:EKSO)

$1.47 -0.01 (-0.68 %)
(As of 02/21/2018 04:00 PM ET)
Previous Close$1.47
Today's Range$1.47 - $1.51
52-Week Range$0.99 - $4.77
Volume159,429 shs
Average Volume543,409 shs
Market Capitalization$92.85 million
P/E Ratio-1.58
Dividend YieldN/A
Beta1.47

About Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics logoEkso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company’s Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a license agreement with Lockheed Martin Corporation to develop products for military applications, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital.

Receive EKSO News and Ratings via Email

Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:EKSO
CUSIPN/A
Phone510-984-1761

Debt

Debt-to-Equity Ratio0.18%
Current Ratio6.09%
Quick Ratio5.73%

Price-To-Earnings

Trailing P/E Ratio-1.58064516129032
Forward P/E Ratio-1.81
P/E GrowthN/A

Sales & Book Value

Annual Sales$14.22 million
Price / Sales6.19
Cash FlowN/A
Price / CashN/A
Book Value$0.30 per share
Price / Book4.90

Profitability

Trailing EPS($0.93)
Net Income$-23,470,000.00
Net Margins-343.53%
Return on Equity-323.00%
Return on Assets-113.54%

Miscellaneous

Employees108
Outstanding Shares59,900,000

Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions

What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?

Shares of Ekso Bionics reverse split on the morning of Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) issued its earnings results on Wednesday, November, 8th. The company reported ($0.18) EPS for the quarter, missing the Zacks' consensus estimate of ($0.13) by $0.05. The business earned $1.60 million during the quarter, compared to analysts' expectations of $2.40 million. Ekso Bionics had a negative net margin of 343.53% and a negative return on equity of 323.00%. View Ekso Bionics' Earnings History.

Where is Ekso Bionics' stock going? Where will Ekso Bionics' stock price be in 2018?

1 brokerages have issued 12 month price targets for Ekso Bionics' shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate Ekso Bionics' stock price to reach $4.00 in the next twelve months. View Analyst Ratings for Ekso Bionics.

Who are some of Ekso Bionics' key competitors?

Who owns Ekso Bionics stock?

Ekso Bionics' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (0.39%), Advisor Group Inc. (0.19%) and BlackRock Inc. (0.19%). Company insiders that own Ekso Bionics stock include Amy Mcbride Wendell, Max Scheder-Bieschin, Russ Angold and Thomas Looby. View Institutional Ownership Trends for Ekso Bionics.

Who bought Ekso Bionics stock? Who is buying Ekso Bionics stock?

Ekso Bionics' stock was purchased by a variety of institutional investors in the last quarter, including Advisor Group Inc., Geode Capital Management LLC and BlackRock Inc.. Company insiders that have bought Ekso Bionics stock in the last two years include Amy Mcbride Wendell, Max Scheder-Bieschin and Thomas Looby. View Insider Buying and Selling for Ekso Bionics.

How do I buy Ekso Bionics stock?

Shares of Ekso Bionics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ekso Bionics' stock price today?

One share of Ekso Bionics stock can currently be purchased for approximately $1.47.

How big of a company is Ekso Bionics?

Ekso Bionics has a market capitalization of $92.85 million and generates $14.22 million in revenue each year. The company earns $-23,470,000.00 in net income (profit) each year or ($0.93) on an earnings per share basis. Ekso Bionics employs 108 workers across the globe.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected]


MarketBeat Community Rating for Ekso Bionics (EKSO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  162 (Vote Outperform)
Underperform Votes:  134 (Vote Underperform)
Total Votes:  296
MarketBeat's community ratings are surveys of what our community members think about Ekso Bionics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Ekso Bionics (NASDAQ:EKSO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.00$4.00$4.00$6.00
Price Target Upside: 145.40% upside145.40% upside145.40% upside268.10% upside

Ekso Bionics (NASDAQ:EKSO) Consensus Price Target History

Price Target History for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ:EKSO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017B. RileyReiterated RatingBuy$4.00HighView Rating Details
10/14/2016SunTrust BanksInitiated CoverageBuyN/AView Rating Details
7/31/2016Rodman & RenshawReiterated RatingBuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Ekso Bionics (NASDAQ:EKSO) Earnings History and Estimates Chart

Earnings by Quarter for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ EKSO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017Q3 2017($0.13)($0.18)$2.40 million$1.60 millionViewN/AView Earnings Details
8/7/2017Q2 2017($0.32)($0.32)$2.00 million$1.87 millionViewN/AView Earnings Details
5/9/2017Q1 2017($0.41)($0.38)$2.38 million$1.44 millionViewListenView Earnings Details
3/7/2017Q4 2016($0.39)($0.41)$2.59 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.41)($0.51)$1.79 million$1.60 millionViewN/AView Earnings Details
7/28/2016Q2 2016($0.28)($0.71)$2.14 million$1.55 millionViewN/AView Earnings Details
5/10/2016Q1 2016($0.63)$8.49 millionViewN/AView Earnings Details
3/14/2016Q4 2015($0.63)$2.54 million$1.94 millionViewN/AView Earnings Details
11/5/2015Q3 2015($0.04)($0.05)$2.55 million$2.92 millionViewN/AView Earnings Details
8/11/2015Q2 2015($0.04)($0.06)$2.00 million$2.11 millionViewN/AView Earnings Details
5/7/2015Q1 2015($0.35)($0.28)$1.76 million$1.69 millionViewN/AView Earnings Details
3/17/2015Q4 2014($0.03)($0.06)$1.48 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Ekso Bionics (NASDAQ:EKSO) Earnings Estimates

2018 EPS Consensus Estimate: ($0.93)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.39)($0.07)($0.23)
Q2 20182($0.39)($0.09)($0.24)
Q3 20182($0.37)($0.08)($0.23)
Q4 20182($0.36)($0.10)($0.23)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Ekso Bionics (NASDAQ:EKSO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Ekso Bionics (NASDAQ EKSO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.32%
Institutional Ownership Percentage: 6.41%
Insider Trades by Quarter for Ekso Bionics (NASDAQ:EKSO)
Institutional Ownership by Quarter for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ EKSO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2017Russ AngoldInsiderSell50,000$3.51$175,500.00View SEC Filing  
9/14/2017Amy Mcbride WendellDirectorBuy16,264$1.23$20,004.7216,264View SEC Filing  
9/8/2017Thomas LoobyCEOBuy15,000$1.13$16,950.0020,315View SEC Filing  
9/7/2017Max Scheder-BieschinCFOBuy10,000$1.13$11,300.0032,371View SEC Filing  
8/23/2017Russ AngoldInsiderSell9,352$1.33$12,438.16241,326View SEC Filing  
8/16/2017Russ AngoldInsiderSell28,254$1.53$43,228.62250,678View SEC Filing  
8/15/2017Russ AngoldInsiderSell221,746$1.55$343,706.30400,678View SEC Filing  
11/11/2016Max Scheder-BieschinCFOBuy1,000$4.00$4,000.009,817View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Ekso Bionics (NASDAQ EKSO) News Headlines

Source:
DateHeadline
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - February 14 at 3:40 PM
BRIEF-Ekso Bionics To Expand Clinical Trial Sites For Comparative Multicenter WISE StudyBRIEF-Ekso Bionics To Expand Clinical Trial Sites For Comparative Multicenter WISE Study
www.reuters.com - February 12 at 3:38 PM
EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Ekso Bionics Holdings, Inc. InvestorsEKSO INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
finance.yahoo.com - February 12 at 3:38 PM
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSOSHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSO
finance.yahoo.com - February 10 at 8:43 AM
Ekso Bionics Holdings, Inc. Reminder: Important March 5, 2018 Lead Plaintiff Deadline in Class Action - EKSOEkso Bionics Holdings, Inc. Reminder: Important March 5, 2018 Lead Plaintiff Deadline in Class Action - EKSO
finance.yahoo.com - February 8 at 3:36 PM
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO) - Business Wire (press release)Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO) - Business Wire (press release)
www.businesswire.com - February 8 at 8:05 AM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - February 8 at 8:05 AM
IMPORTANT EKSO BIONICS HOLDINGS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who suffered losses in Ekso Bionics Holdings, Inc.IMPORTANT EKSO BIONICS HOLDINGS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who suffered losses in Ekso Bionics Holdings, Inc.
finance.yahoo.com - February 8 at 8:05 AM
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.
finance.yahoo.com - February 8 at 8:05 AM
Report: Exploring Fundamental Drivers Behind Dow Chemical, Bank Of New York Mellon, New York Community, Frontier Communications, TAL Education Group, and Ekso Bionics — New Horizons, Emerging Trends, and Upcoming DevelopmentsReport: Exploring Fundamental Drivers Behind Dow Chemical, Bank Of New York Mellon, New York Community, Frontier Communications, TAL Education Group, and Ekso Bionics — New Horizons, Emerging Trends, and Upcoming Developments
finance.yahoo.com - February 7 at 8:23 AM
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO)Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO)
finance.yahoo.com - February 6 at 3:36 PM
DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ekso Bionics Holdings, Inc. to Contact the FirmDEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ekso Bionics Holdings, Inc. to Contact the Firm
finance.yahoo.com - February 6 at 8:25 AM
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.
finance.yahoo.com - February 5 at 3:35 PM
Ekso Bionics Holdings, Inc. (EKSO) Expected to Post Earnings of -$0.10 Per ShareEkso Bionics Holdings, Inc. (EKSO) Expected to Post Earnings of -$0.10 Per Share
www.americanbankingnews.com - February 5 at 1:10 AM
EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. InvestorsEKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
www.bizjournals.com - February 1 at 3:36 PM
EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. InvestorsEKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
finance.yahoo.com - February 1 at 3:36 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - February 1 at 3:36 PM
Ekso Bionics (EKSO) Co-Founder Russ Angold to Step DownEkso Bionics (EKSO) Co-Founder Russ Angold to Step Down
www.streetinsider.com - January 27 at 8:23 AM
Ekso Bionics® Announces Leadership TransitionEkso Bionics® Announces Leadership Transition
finance.yahoo.com - January 27 at 8:23 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - EKSOSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - EKSO
finance.yahoo.com - January 27 at 8:23 AM
NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. – EKSONOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. – EKSO
finance.yahoo.com - January 26 at 3:37 PM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - January 25 at 3:37 PM
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
finance.yahoo.com - January 25 at 8:28 AM
Report: Exploring Fundamental Drivers Behind Flowers Foods, Mednax, Ekso Bionics, 1st Source, Myers Industries, and USA Compression Partners, LP — New Horizons, Emerging Trends, and Upcoming DevelopmentsReport: Exploring Fundamental Drivers Behind Flowers Foods, Mednax, Ekso Bionics, 1st Source, Myers Industries, and USA Compression Partners, LP — New Horizons, Emerging Trends, and Upcoming Developments
finance.yahoo.com - January 22 at 8:13 AM
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ekso Bionics Holdings, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action LawsuitINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ekso Bionics Holdings, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit
finance.yahoo.com - January 20 at 9:53 AM
 Brokerages Anticipate Ekso Bionics Holdings, Inc. (EKSO) Will Announce Earnings of -$0.10 Per Share Brokerages Anticipate Ekso Bionics Holdings, Inc. (EKSO) Will Announce Earnings of -$0.10 Per Share
www.americanbankingnews.com - January 19 at 3:30 AM
Bragar Eagel & Squire, PC Reminds Investors That a Class Action Lawsuit Has Been Filed Against Ekso Bionics ... - Business Wire (press release)Bragar Eagel & Squire, PC Reminds Investors That a Class Action Lawsuit Has Been Filed Against Ekso Bionics ... - Business Wire (press release)
www.businesswire.com - January 18 at 10:43 AM
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Ekso Bionics Holdings, Inc. (EKSO) and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Ekso Bionics Holdings, Inc. (EKSO) and Encourages Investors to Contact the Firm
finance.yahoo.com - January 17 at 5:08 PM
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. - EKSOSHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. - EKSO
finance.yahoo.com - January 17 at 5:08 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSOSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSO
finance.yahoo.com - January 17 at 5:08 PM
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. - GlobeNewswire (press release)Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. - GlobeNewswire (press release)
globenewswire.com - January 15 at 9:41 AM
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.
feeds.benzinga.com - January 14 at 2:27 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - EKSOSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - EKSO
finance.yahoo.com - January 13 at 9:44 AM
EKSO LOSS ALERT: Rosen Law Firm Reminds Ekso Bionics Holdings, Inc. Investors of Important Deadline in First Filed Class Action – EKSOEKSO LOSS ALERT: Rosen Law Firm Reminds Ekso Bionics Holdings, Inc. Investors of Important Deadline in First Filed Class Action – EKSO
finance.yahoo.com - January 12 at 4:52 PM
Ekso Bionics Holdings, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Possible Breaches of Fiduciary Duty by Officers and DirectorsEkso Bionics Holdings, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Possible Breaches of Fiduciary Duty by Officers and Directors
finance.yahoo.com - January 11 at 5:09 PM
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) To Contact Brower Piven Before The Lead Plaintiff DeadlineSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) To Contact Brower Piven Before The Lead Plaintiff Deadline
feeds.benzinga.com - January 11 at 1:09 AM
Pomerantz Law Firm Announces the Filing of a Class Action against Ekso Bionics Holdings, Inc. and Certain Officers – EKSOPomerantz Law Firm Announces the Filing of a Class Action against Ekso Bionics Holdings, Inc. and Certain Officers – EKSO
finance.yahoo.com - January 10 at 5:00 PM
UPDATE - Pomerantz Law Firm Announces the Filing of a Class Action against Ekso Bionics Holdings, Inc. and Certain Officers – EKSOUPDATE - Pomerantz Law Firm Announces the Filing of a Class Action against Ekso Bionics Holdings, Inc. and Certain Officers – EKSO
finance.yahoo.com - January 10 at 5:00 PM
Ekso Bionics (EKSO) Upgraded to "Hold" at Zacks Investment ResearchEkso Bionics (EKSO) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - January 9 at 11:20 PM
Lawsuit for Investors in Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) Shares Announced by Shareholders FoundationLawsuit for Investors in Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) Shares Announced by Shareholders Foundation
finance.yahoo.com - January 9 at 9:46 AM
Harwood Feffer LLP Announces Investigation of Ekso Bionics Holdings, Inc. - Business Wire (press release)Harwood Feffer LLP Announces Investigation of Ekso Bionics Holdings, Inc. - Business Wire (press release)
www.businesswire.com - January 8 at 5:10 PM
Harwood Feffer LLP Announces Investigation of Ekso Bionics Holdings, Inc.Harwood Feffer LLP Announces Investigation of Ekso Bionics Holdings, Inc.
finance.yahoo.com - January 8 at 5:07 PM
Mid-Afternoon Market Update: LiNiu Technology Surges Following 1H17 Results; Ekso Bionics Shares Slide - BenzingaMid-Afternoon Market Update: LiNiu Technology Surges Following 1H'17 Results; Ekso Bionics Shares Slide - Benzinga
www.benzinga.com - December 30 at 4:55 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ekso Bionics Holdings, Inc ... - PR Newswire (press release)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ekso Bionics Holdings, Inc ... - PR Newswire (press release)
www.prnewswire.com - December 29 at 10:19 AM
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Ekso Bionics Holdings, Inc. - Business Wire (press release)EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Ekso Bionics Holdings, Inc. - Business Wire (press release)
www.businesswire.com - December 29 at 10:19 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ekso Bionics Holdings, Inc. - EKSOSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ekso Bionics Holdings, Inc. - EKSO
finance.yahoo.com - December 28 at 3:40 PM
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Ekso Bionics Holdings, Inc.EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Ekso Bionics Holdings, Inc.
finance.yahoo.com - December 28 at 3:40 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ekso Bionics Holdings, Inc. (EKSO)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ekso Bionics Holdings, Inc. (EKSO)
finance.yahoo.com - December 28 at 3:40 PM
Zacks: Brokerages Set $10.00 Price Target for Ekso Bionics Holdings, Inc. (EKSO)Zacks: Brokerages Set $10.00 Price Target for Ekso Bionics Holdings, Inc. (EKSO)
www.americanbankingnews.com - December 26 at 7:20 AM
BRIEF-Ekso Bionic Partners With HASOMED To Launch Functional Electrical Stimulation For The EksoGT ExoskeletonBRIEF-Ekso Bionic Partners With HASOMED To Launch Functional Electrical Stimulation For The EksoGT Exoskeleton
www.reuters.com - December 14 at 5:35 PM

SEC Filings

Ekso Bionics (NASDAQ:EKSO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Ekso Bionics (NASDAQ EKSO) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.